The expression of Distal-Less Homeobox 1 (DLX1) was found to be much higher in PCa than BPH when used as potential clinical biomarkers for PCa diagnosis, which plays a role in PCa progression [12]. The gene discussed is DLX1; the disease is benign prostatic hyperplasia.